What is the clinical evidence from this study?

Study design: Observational. Population: Acute myocardial infarction (n=335). Intervention: Evidence-based management. Primary outcome: All cause mortality (p=<0.00001).

What question did this study set out to answer?

To evaluate the compliance of acute myocardial infarction management practices with established guidelines in a community hospital.

April 13, 2026

Management of acute myocardial infarction.

Q: What are the key findings of this study?

Management of acute myocardial infarction in a major Riyadh hospital was largely compliant with evidence-based practice, with an all-cause mortality rate of 6.6%.

Q: What question did this study set out to answer?

To evaluate the compliance of acute myocardial infarction management practices with established guidelines in a community hospital.

Key Result

Management of acute myocardial infarction in a major Riyadh hospital was largely compliant with evidence-based practice, with an all-cause mortality rate of 6.6%.

Key Points

To evaluate the compliance of acute myocardial infarction management practices with established guidelines in a community hospital.
Data collection from patients admitted with acute myocardial infarction in a community hospital
Analysis of therapeutic modalities administered upon admission and discharge medications
Comparison of patient outcomes with current clinical guidelines
335 patients diagnosed with acute myocardial infarction were admitted, predominantly male (94%)
80.9% of patients received thrombolytic therapy
76.1% were discharged on beta-blockers, and 61.5% on angiotensin converting enzyme inhibitors
93.4% of patients were alive post-treatment, suggesting effective management

Study Design

Type

Observational (n=335)

Multicenter

Structured PICO

Is the current practice in managing patients admitted with acute MI in a major community hospital in Riyadh compliant with evidence-based guidelines?

Population

335 patients admitted to the Coronary Care Unit with a diagnosis of acute myocardial infarction over a one-year period (April 1999 to April 2000), 94% male, in Riyadh, Kingdom of Saudi Arabia.

Intervention

Current clinical practice for acute MI management (including thrombolytic therapy and discharge medications)

Outcome

Administration of therapeutic modalities upon admission, discharge medications, and all-cause mortality post treatmenthard clinical

Management of acute MI in this Saudi Arabian community hospital was largely compliant with evidence-based practice, though underutilization of ACE inhibitors and hypolipidemic agents was noted.

Main Result

p-value: p=<0.00001

Abstract

OBJECTIVE: Acute myocardial infarction (MI) is a major health problem with a substantial fatality and morbidity. The management of patients with acute MI has been addressed in major trials to improve the survival and enhance the quality of life of the patients. Numerous guidelines have been established for the management of such patients. The objective of this study is to determine whether the current practice in managing patients admitted with acute MI in a major community hospital in Riyadh is evidence based compliant. METHODS: The data were collected from patients admitted to the Coronary Care Unit (CCU), Riyadh Medical Complex (RMC), Riyadh, Kingdom of Saudi Arabia, a 1500 bed community hospital, with a diagnosis of acute MI over one-year period (April 1999 to April 2000). The administration of different therapeutic modalities upon admission as well as discharge medications was obtained. Patients outcome (all cause mortality) post treatment were collected. The data was analyzed and compared with the current guidelines. RESULTS: A total of 335 patients, 315 males (94%), were admitted to the CCU of RMC with a diagnosis of acute MI. Two hundred and seventy-one patients (80.9%) received thrombolytic therapy. Discharge medications were beta-blocker in 255 (76.1%), angiotensin converting enzyme inhibitors in 206 (61.5%), nitrates in 281 (83.9%), hypolipidemic agents in 15 patients (4.5%), and aspirin in all patients. The outcome of these patients obtained either alive or dead was 313 (93.4%) and 22 (6.6%) (p<0.00001). CONCLUSION: The patients with acute MI received management compliant with evidence-based practice. However, more awareness to the use of angiotensin converting enzyme inhibitors as well as hypolipidemic agents is needed to provide maximum benefit to these patients. Moreover, national guidelines for the management of acute MI are needed for improvement of quality of care.

Bookmark